VRDNViridian Therapeutics, Inc.
$22.36-2.8% 1Y
$22.36
$13.3052 weeks$33.78
Is the price fair?
What VRDN's price assumes
Viridian Therapeutics, Inc. did not earn a profit over the last twelve months, so it has no trailing P/E and the price is measured against sales instead: 35.6× revenue.
35.6
Price / sales · no P/E: the last twelve months did not end in a profit
- Price / book
- 3.83
Price / book · today's price, trailing year to Jun 30, 2026
- EV / sales
- 23.4
EV / sales
Details›
- Price / booktoday's price, trailing year to Jun 30, 2026
- 3.83
- EV / EBIToperating margin −570%: the multiple describes the denominator
- not meaningful
- EV / salestoday's price, trailing year to Jun 30, 2026
- 23.4
- Market capitalisation113.3 million shares, counted Aug 3, 2026
- $2.53B
Multiples from SEC filings and end-of-day closes; implied growth from a reverse discounted cash flow. Group medians across the names Ryufin tracks.
On our screens:Most shorted stocks